Effect of perioperative factors on short-term outcomes in patients with non-small cell lung cancer over 60 years of age

Author:

Zhu Wenzhi1,Yang Jiaonan1,Wang Xiaoyi1,Ji Xinqiang1,Tan Hongyu1

Affiliation:

1. Peking University Cancer Hospital

Abstract

Abstract Background: People in China have gradually entered old age society, and the number of lung cancer cases is expected to increase annually among the elderly. This study aimed to retrospectively explore the association between perioperative factors and short-term outcomes in elderly patients with non-small cell lung cancer (NSCLC). Methods: A total of 490 elderly patients with NSCLC between January 1, 2003, and December 31, 2009, were selected. Perioperative factors were grouped and analyzed according to postoperative complications and length of hospital stay. A logistic regression analysis model was used to screen for the independent predictors of patient prognosis. The primary endpoint was postoperative complications and the secondary endpoint was postoperative hospital stay. Results: Of all patients, 344 (70.2%) developed postoperative complications, and the average length of stay after surgery was14.0±5.6 days. Perioperative fentanyl equivalents>28.7μg/kg and duration of surgery>4.4h were associated were associated with an increased risk of PPCs (P < 0.05);intraoperative blood loss(IBL) > 200 ml was associated with extended hospital stay (P < 0.05). Conclusions: This study suggested that Perioperative factors may affect the short-term prognosis of elderly NSCLC patients after surgery. Perioperative fentanyl equivalents>28.7μg/kg, surgery duration, and IBL may be independent predictors of short-term outcomes in elderly patients.

Publisher

Research Square Platform LLC

Reference29 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung H;CA Cancer J Clin,2021

2. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020;Wei C;Chin Med J,2021

3. Trend Analysis for the Choice and Cost of Lung Cancer Treatment in South Korea, 2003–2013;Dohun K;Cancer Res Treat,2018

4. Comparison of single-agent chemotherapy and targeted therapy to first-line treatment in patients aged 80 years and older with advanced non-small cell lung cancer;Qianqian Z;Onco Targets Ther,2015

5. A review of the management of elderly patients with non-small-cell lung cancer;Blanco R;Ann Oncol,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3